AMENDMENT NO. 1 TO RESTATED AND AMENDED LICENSE AGREEMENTLicense Agreement • October 13th, 2021 • MDxHealth SA • Services-medical laboratories • Maryland
Contract Type FiledOctober 13th, 2021 Company Industry JurisdictionThis AMENDMENT NO.1 TO THE RESTATED AND AMENDED LICENSE AGREEMENT (this “Amendment”) is entered into as of April 15th, 2005, by and between The Johns Hopkins University, a Maryland corporation having an address at 3400 N. Charles St., Baltimore, MD 21218 (“JHU”) and OncoMethylome Sciences S.A. (formerly known as OncoGenome Sciences, S.A.), a corporation having an address at Niveau +2, Tour 4 de Pharmacie (batiment 36), Ulg CHU, Av. de l’Hopital no. 1, 4000 Sart-Tilman (Liege), Belgium (“Company”), with respect to the following:
AMENDMENT NO. 1 TO RESTATED AND AMENDED LICENSE AGREEMENTLicense Agreement • September 23rd, 2021 • MDxHealth SA • Services-medical laboratories • Maryland
Contract Type FiledSeptember 23rd, 2021 Company Industry JurisdictionThis AMENDMENT NO.1 TO THE RESTATED AND AMENDED LICENSE AGREEMENT (this “Amendment”) is entered into as of April 15th, 2005, by and between The Johns Hopkins University, a Maryland corporation having an address at 3400 N. Charles St., Baltimore, MD 21218 (“JHU”) and OncoMethylome Sciences S.A. (formerly known as OncoGenome Sciences, S.A.), a corporation having an address at Niveau +2, Tour 4 de Pharmacie (batiment 36), Ulg CHU, Av. de l’Hopital no. 1, 4000 Sart-Tilman (Liege), Belgium (“Company”), with respect to the following: